Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge
10.4142/jvs.2018.19.2.232
- Author:
Ke DING
1
;
Ke SHANG
;
Zu Hua YU
;
Chuan YU
;
Yan Yan JIA
;
Lei HE
;
Cheng Shui LIAO
;
Jing LI
;
Chun Jie ZHANG
;
Yin Ju LI
;
Ting Cai WU
;
Xiang Chao CHENG
Author Information
1. Key Laboratory of Animal Disease and Public Health, Henan University of Science and Technology, and Key Laboratory of Live Carrier Biomaterial and Animal Disease Prevention and Control, Luoyang 471003, China. chengxch66@163.com
- Publication Type:Original Article
- Keywords:
HN protein;
Newcastle disease virus;
immune protective response;
recombinant-attenuated Salmonella Pullorum;
vaccines
- MeSH:
Animals;
Antibodies;
Bacteria;
Chickens;
Hemagglutination;
HN Protein;
Homologous Recombination;
Immunoglobulin A, Secretory;
Immunoglobulin G;
Lymphocytes;
Methods;
Newcastle disease virus;
Newcastle Disease;
Plasmids;
Poultry;
Salmonella;
Suicide;
Vaccines
- From:Journal of Veterinary Science
2018;19(2):232-241
- CountryRepublic of Korea
- Language:English
-
Abstract:
Newcastle disease virus (NDV) and Salmonella Pullorum have significant damaging effects on the poultry industry, but no previous vaccine can protect poultry effectively. In this study, a recombinant-attenuated S. Pullorum strain secreting the NDV hemagglutinin-neuraminidase (HN) protein, C79-13ΔcrpΔasd (pYA-HN), was constructed by using the suicide plasmid pREasd-mediated bacteria homologous recombination method to form a new bivalent vaccine candidate against Newcastle disease (ND) and S. Pullorum disease (PD). The effect of this vaccine candidate was compared with those of the NDV LaSota and C79-13ΔcrpΔasd (pYA) strains. The serum hemagglutination inhibition antibody titers, serum immunoglobulin G (IgG) antibodies, secretory IgA, and stimulation index in lymphocyte proliferation were increased significantly more (p < 0.01) in chickens inoculated with C79-13ΔcrpΔasd (pYA-HN) than with C79-13ΔcrpΔasd (pYA) but were not significantly increased compared with the chickens immunized with the LaSota live vaccine (p > 0.05). Moreover, the novel strain provides 60% and 80% protective efficacy against the NDV virulent strain F48E9 and the S. Pullorum virulent strain C79-13. In summary, in this study, a recombinant-attenuated S. Pullorum strain secreting NDV HN protein was constructed. The generation of the S. Pullorum C79-13ΔcrpΔasd (pYA-HN) strain provides a foundation for the development of an effective living-vector double vaccine against ND and PD.
